Early MR Lymphography with Gadofluorine M in Rabbits
- 1 June 2004
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 231 (3) , 682-688
- https://doi.org/10.1148/radiol.2313021000
Abstract
To investigate the dose and time dependency of gadofluorine M for lymph node imaging and the detection of lymph node metastases in an animal model and to compare gadofluorine M with Gadomer (both, Schering, Berlin, Germany) for lymph node enhancement.Enhancement of popliteal and iliac lymph nodes was studied in VX2 tumor-bearing rabbits before injection and at 5-120 minutes and 24 hours after intravenous bolus injection of 0.025, 0.05, and 0.1 mmol gadolinium per kilogram of body weight gadofluorine M (six rabbits) or 0.5 mmol/kg Gadomer (eight rabbits). Effects of treatment and time point at enhancement were evaluated with repeated measures analysis of variance. Means were separated with all-pairs comparison with Tukey-Kramer adjustment. After 1.5-T magnetic resonance (MR) imaging, lymph nodes were removed, and prepared sections were stained with hematoxylin-eosin for microscopic examination.MR images in VX2 tumor-bearing rabbits revealed rapid and strong signal intensity increase in the functional lymph node tissue by 15 minutes after intravenous injection of gadofluorine M. Maximum enhancement of 165%-309% was observed 60-90 minutes after injection (enhancement with 0.05 and 0.1 mmol/kg significantly different from that with 0.025 mmol/kg, P < or =.05). Metastatic tissue showed only slight enhancement at early time points, resulting in high-contrast differentiation between functional and metastatic tissue. Intravenous injection of the blood-pool agent Gadomer induced only short and inhomogeneous lymph node enhancement (enhancement significantly lower [P < or =.05] than that with gadofluorine M).Findings in the study showed that gadofluorine M produces rapid lymph node accumulation. Diagnosis of lymph node metastases was shown with intravenous injection of gadofluorine M with a minimum effective diagnostic dose of 0.025 mmol/kg.Keywords
This publication has 34 references indexed in Scilit:
- Interstitielle T1-gewichtete MR-Lymphographie mit dem polymeren Kontrastmittel Gadomer-17 im TierexperimentRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 2001
- Lymph node metastases: CT and MRIEuropean Journal of Radiology, 2000
- Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinomaJournal of Magnetic Resonance Imaging, 1999
- Subcutaneous and intravenous delivery of diagnostic agents to the lymphatic system: applications in lymphoscintigraphy and indirect lymphographyAdvanced Drug Delivery Reviews, 1999
- Iron oxide-enhanced MR lymphography: The evaluation of cervical lymph node metastases in head and neck cancerJournal of Magnetic Resonance Imaging, 1997
- Characterization of Reactive Versus Tumor-Bearing Lymph Nodes with Interstitial Magnetic Resonance Lymphography in an Animal ModelInvestigative Radiology, 1995
- Targeting of colloids to lymph nodes: influence of lymphatic physiology and colloidal characteristicsAdvanced Drug Delivery Reviews, 1995
- Cervical lymphadenopathy: ratio of long- to short-axis diameter as a predictor of malignancyThe British Journal of Radiology, 1995
- Investigation of Mechanisms Influencing the Accumulation of Ultrasmall Superparamagnetic Iron Oxide Particles in Lymph NodesInvestigative Radiology, 1995
- MR Lymphography with a Lymphotropic T1‐Type MR Contrast Agent: Gd‐DTPA‐PGMMagnetic Resonance in Medicine, 1995